103 related articles for article (PubMed ID: 28799058)
1. Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?
Froes BP; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
Pediatr Nephrol; 2017 Nov; 32(11):2165-2169. PubMed ID: 28799058
[TBL] [Abstract][Full Text] [Related]
2. Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis.
Cruzado JM; Manonelles A; Rayego-Mateos S; Doladé N; Amaya-Garrido A; Varela C; Guiteras R; Mosquera JL; Jung M; Codina S; Martínez-Valenzuela L; Draibe J; Couceiro C; Vigués F; Madrid Á; Florian MC; Ruíz-Ortega M; Sola A
Kidney Int; 2024 Jul; 106(1):67-84. PubMed ID: 38428734
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of parietal epithelial cell and podocyte extracellular matrix proteins in focal segmental glomerulosclerosis and diabetic nephropathy.
Chan GC; Eng DG; Miner JH; Alpers CE; Hudkins K; Chang A; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1680-F1694. PubMed ID: 31630546
[TBL] [Abstract][Full Text] [Related]
4. Glomerular parietal epithelial expression of CD44 in minimal change nephrotic syndrome and primary focal segmental glomerulosclerosis: A clinico-pathological study.
Paul EN; Satish S; Kelur KK; Shetty MS
Indian J Pathol Microbiol; 2023; 66(3):526-532. PubMed ID: 37530333
[TBL] [Abstract][Full Text] [Related]
5. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
Cheng P; Xie Q; Liu S; Liu X; Wang L; Hao CM
Rev Assoc Med Bras (1992); 2024; 70(4):e20230871. PubMed ID: 38716932
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of C4d expression and staining patterns by immunohistochemistry in renal biopsy samples with focal segmental glomerulosclerosis and minimal change disease.
Abedi M; Nili F; Dehkhoda F; Abdollahi A; Salarvand S
Ann Diagn Pathol; 2024 Jun; 70():152281. PubMed ID: 38417352
[TBL] [Abstract][Full Text] [Related]
7. The Role of Platelet-Derived Growth Factor in Focal Segmental Glomerulosclerosis.
Jia T; Xu T; Smeets B; Buhl EM; Moeller MJ; Floege J; Klinkhammer BM; Boor P
J Am Soc Nephrol; 2023 Feb; 34(2):241-257. PubMed ID: 36351762
[TBL] [Abstract][Full Text] [Related]
8. CD44 impacts glomerular parietal epithelial cell changes in the aged mouse kidney.
Hamatani H; Eng DG; Hiromura K; Pippin JW; Shankland SJ
Physiol Rep; 2020 Jun; 8(12):e14487. PubMed ID: 32597007
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.
Zhong J; Whitman JB; Yang HC; Fogo AB
J Histochem Cytochem; 2019 Sep; 67(9):623-632. PubMed ID: 31116068
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-Parietal Epithelial Cell Interdependence in Glomerular Development and Disease.
Bronstein R; Pace J; Gowthaman Y; Salant DJ; Mallipattu SK
J Am Soc Nephrol; 2023 May; 34(5):737-750. PubMed ID: 36800545
[TBL] [Abstract][Full Text] [Related]
11. A new index for the outcome of focal segmental glomerulosclerosis.
Chan L; Danyi Y; Chen C
Sci Rep; 2024 Apr; 14(1):8278. PubMed ID: 38594302
[TBL] [Abstract][Full Text] [Related]
12. Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN; Alpers CE; Barratt J; Bieler S; Canetta P; Chae DW; Coppock G; Diva U; Gesualdo L; Heerspink HJL; Inrig JK; Kirsztajn GM; Kohan D; Komers R; Kooienga LA; Lieberman K; Mercer A; Noronha IL; Perkovic V; Radhakrishnan J; Rote W; Rovin B; Tesar V; Trimarchi H; Tumlin J; Wong MG; Trachtman H;
N Engl J Med; 2023 Dec; 389(26):2436-2445. PubMed ID: 37921461
[TBL] [Abstract][Full Text] [Related]
13. A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.
Trachtman H; Fervenza FC; Gipson DS; Heering P; Jayne DR; Peters H; Rota S; Remuzzi G; Rump LC; Sellin LK; Heaton JP; Streisand JB; Hard ML; Ledbetter SR; Vincenti F
Kidney Int; 2011 Jun; 79(11):1236-43. PubMed ID: 21368745
[TBL] [Abstract][Full Text] [Related]
14. Castrated autoimmune glomerulonephritis mouse model shows attenuated glomerular sclerosis with altered parietal epithelial cell phenotype.
Otani Y; Ichii O; Masum MA; Namba T; Nakamura T; Kon Y
Exp Biol Med (Maywood); 2021 Jun; 246(11):1318-1329. PubMed ID: 33641441
[TBL] [Abstract][Full Text] [Related]
15. Sparsentan for Focal Segmental Glomerulosclerosis in the DUET Open-Label Extension: Long-term Efficacy and Safety.
Campbell KN; Gesualdo L; Murphy E; Rheault MN; Srivastava T; Tesar V; Komers R; Trachtman H
Kidney Med; 2024 Jun; 6(6):100833. PubMed ID: 38831932
[TBL] [Abstract][Full Text] [Related]
16. Primary focal segmental glomerulosclerosis in children: epidemiology, clinical presentation and prognosis.
Boussetta A; Ben Njima K; Jellouli M; Gargah T
Tunis Med; 2023 Mar; 101(3):373-378. PubMed ID: 38263915
[TBL] [Abstract][Full Text] [Related]
17. C4d expression in focal segmental glomerulosclerosis.
Chávez Valencia V; Pérez-Vázquez V; Gómez García A; Vargas-Ortiz K; Villanueva Pérez MA; Godínez Rubí M; Pazarín Villaseñor L; Gutiérrez Castellanos S; Orizaga de la Cruz C
Nefrologia (Engl Ed); 2024 Jun; ():. PubMed ID: 38906767
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics, pathology, and prognosis of 77 dogs with focal segmental glomerulosclerosis.
Lorbach SK; Hokamp JA; Quimby JM; Cianciolo RE
J Vet Intern Med; 2020 Sep; 34(5):1948-1956. PubMed ID: 33463760
[TBL] [Abstract][Full Text] [Related]
19. Urinary SPP1 has potential as a non-invasive diagnostic marker for focal segmental glomerulosclerosis.
Ye Q; Xu G; Xue C; Pang S; Xie B; Huang G; Li H; Chen X; Yang R; Li W
FEBS Open Bio; 2023 Nov; 13(11):2061-2080. PubMed ID: 37696527
[TBL] [Abstract][Full Text] [Related]
20. Oligonephronia: another piece in the CKDu jigsaw?
Hoy WE; Bertram JF
Kidney Int; 2024 Apr; 105(4):671-673. PubMed ID: 38519234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
